Literature DB >> 21911571

Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Mirva Lehtopolku1, Pirkko Kotilainen, Marjo Haanperä-Heikkinen, Ulla-Maija Nakari, Marja-Liisa Hänninen, Pentti Huovinen, Anja Siitonen, Erkki Eerola, Jari Jalava, Antti J Hakanen.   

Abstract

The aim of this study was to examine macrolide resistance mutations in Campylobacter species. In 76 strains studied, point mutation A to G at position 2059 of the 23S rRNA gene was detected in 30 of the 33 erythromycin-resistant strains. An amino acid insertion in the ribosomal protein L22 was found in one resistant strain without a 23S rRNA mutation. The A2059G mutation is the main cause of macrolide resistance in Campylobacter species.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21911571      PMCID： PMC3232809          DOI： 10.1128/AAC.00314-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program.

Authors:  Ronald N Jones; David J Farrell; Ian Morrissey
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.

Authors:  Marjo Haanperä; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  In vitro activity of azithromycin against nontyphoidal Salmonella enterica.

Authors:  Marianne Gunell; Pirkko Kotilainen; Jari Jalava; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

5.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp.

Authors:  Sylvie Vacher; Armelle Ménard; Elisabeth Bernard; Francis Mégraud
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 7.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

8.  Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli.

Authors:  H S Chittum; W S Champney
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

9.  Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli.

Authors:  Sophie Payot; Laetitia Avrain; Catherine Magras; Karine Praud; Axel Cloeckaert; Elisabeth Chaslus-Dancla
Journal:  Int J Antimicrob Agents       Date:  2004-05       Impact factor: 5.283

10.  Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000.

Authors:  Antti J Hakanen; Mirva Lehtopolku; Anja Siitonen; Pentti Huovinen; Pirkko Kotilainen
Journal:  J Antimicrob Chemother       Date:  2003-11-12       Impact factor: 5.790
View more
  16 in total

1.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

2.  Down-regulation of ribosomal protein L22 in non-small cell lung cancer.

Authors:  Mingxia Yang; Haibo Sun; Hong Wang; Shijiang Zhang; Xiaowei Yu; Lei Zhang
Journal:  Med Oncol       Date:  2013-06-25       Impact factor: 3.064

Review 3.  [Gastrointestinal infections].

Authors:  C Lübbert; R Mutters
Journal:  Internist (Berl)       Date:  2017-02       Impact factor: 0.743

Review 4.  [Drug therapy of infectious diarrhea: part 1: acute diarrhea].

Authors:  C Lübbert; S Weis
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

5.  Large Sequence Diversity within the Biosynthesis Locus and Common Biochemical Features of Campylobacter coli Lipooligosaccharides.

Authors:  Alejandra Culebro; Joana Revez; Ben Pascoe; Yasmin Friedmann; Matthew D Hitchings; Jacek Stupak; Samuel K Sheppard; Jianjun Li; Mirko Rossi
Journal:  J Bacteriol       Date:  2016-09-22       Impact factor: 3.490

6.  Macrolide resistance mechanisms and virulence factors in erythromycin-resistant Campylobacter species isolated from chicken and swine feces and carcasses.

Authors:  Suk-Kyung Lim; Dong-Chan Moon; Myung Hwa Chae; Hae Ji Kim; Hyang-Mi Nam; Su-Ran Kim; Gum-Chan Jang; Kichan Lee; Suk-Chan Jung; Hee-Soo Lee
Journal:  J Vet Med Sci       Date:  2016-09-02       Impact factor: 1.267

7.  Molecular Basis of Macrolide Resistance in Campylobacter Strains Isolated from Poultry in South Korea.

Authors:  Bai Wei; Min Kang
Journal:  Biomed Res Int       Date:  2018-07-05       Impact factor: 3.411

8.  Antimicrobial Resistance Profiles and Macrolide Resistance Mechanisms of Campylobacter coli Isolated from Pigs and Chickens.

Authors:  Ji-Hyun Choi; Dong Chan Moon; Abraham Fikru Mechesso; Hee Young Kang; Su-Jeong Kim; Hyun-Ju Song; Soon-Seek Yoon; Suk-Kyung Lim
Journal:  Microorganisms       Date:  2021-05-17

Review 9.  Resistance mechanisms in Campylobacter jejuni.

Authors:  Nicole M Iovine
Journal:  Virulence       Date:  2013-02-13       Impact factor: 5.882

10.  The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway.

Authors:  Kan Ni; Zhiqi Huang; Yichun Zhu; Dandan Xue; Qin Jin; Chunhui Zhang; Changjiang Gu
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.